515 related articles for article (PubMed ID: 12004349)
1. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
2. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
3. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with the development of skin cancer after liver transplantation.
Mithoefer AB; Supran S; Freeman RB
Liver Transpl; 2002 Oct; 8(10):939-44. PubMed ID: 12360438
[TBL] [Abstract][Full Text] [Related]
5. [Incidence of de novo neoplasms after liver transplantation].
Berenguer M; Prieto M; Bustamante M; Carrasco D; López-Andújar R; Mir J; Berenguer J
Med Clin (Barc); 1998 Oct; 111(13):481-4. PubMed ID: 9859063
[TBL] [Abstract][Full Text] [Related]
6. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
8. Cancer incidence and survival in kidney transplant patients.
Navarro MD; López-Andréu M; Rodríguez-Benot A; Agüera ML; Del Castillo D; Aljama P
Transplant Proc; 2008 Nov; 40(9):2936-40. PubMed ID: 19010153
[TBL] [Abstract][Full Text] [Related]
9. De novo tumors after liver transplantation: a single-institution experience.
Sanchez EQ; Marubashi S; Jung G; Levy MF; Goldstein RM; Molmenti EP; Fasola CG; Gonwa TA; Jennings LW; Brooks BK; Klintmalm GB
Liver Transpl; 2002 Mar; 8(3):285-91. PubMed ID: 11910575
[TBL] [Abstract][Full Text] [Related]
10. Incidence of de novo nonmelanoma skin tumors after liver transplantation for alcoholic and nonalcoholic liver diseases.
Jiménez-Romero C; Manrique Municio A; Marqués Medina E; Colina F; Ortega Domene P; Gómez Sanz R; Meneu Diaz JC; Abradelo de Usera M; Moreno Elola A; Moreno Gonzalez E
Transplant Proc; 2006 Oct; 38(8):2505-7. PubMed ID: 17097982
[TBL] [Abstract][Full Text] [Related]
11. De novo esophageal neoplasia after liver transplantation.
Presser SJ; Schumacher G; Neuhaus R; Thuss-Patience P; Stieler J; Neuhaus P
Liver Transpl; 2007 Mar; 13(3):443-50. PubMed ID: 17318861
[TBL] [Abstract][Full Text] [Related]
12. Development of lymphoproliferative disease after liver transplantation.
Marqués E; Jiménez C; Manrique A; Vallejo GH; Clemares M; Ortega P; Moreno E
Transplant Proc; 2008 Nov; 40(9):2988-9. PubMed ID: 19010169
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for development of de novo neoplasia after liver transplantation.
Xiol X; Guardiola J; Menendez S; Lama C; Figueras J; Marcoval J; Serrano T; Botargues JM; Mañer M; Rota R
Liver Transpl; 2001 Nov; 7(11):971-5. PubMed ID: 11699033
[TBL] [Abstract][Full Text] [Related]
14. Nonmelanoma skin cancer after liver transplantation. Study of risk factors.
Herrero JI; España A; Quiroga J; Sangro B; Pardo F; Alvárez-Cienfuegos J; Prieto J
Liver Transpl; 2005 Sep; 11(9):1100-6. PubMed ID: 16123952
[TBL] [Abstract][Full Text] [Related]
15. Late acute rejection after liver transplantation: the Western Canada experience.
Ramji A; Yoshida EM; Bain VG; Kneteman NM; Scudamore CH; Ma MM; Steinbrecher UP; Gutfreund KS; Erb SR; Partovi N; Chung SW; Shapiro J; Wong WW
Liver Transpl; 2002 Oct; 8(10):945-51. PubMed ID: 12360439
[TBL] [Abstract][Full Text] [Related]
16. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
17. De novo posttransplantation nonlymphoproliferative malignancies in liver transplant recipients.
Boin I; Leonardi MI; Stucchi RB; Ataide EC; Almeida JR; Barros RH; Leonardi LS
Transplant Proc; 2007 Dec; 39(10):3284-6. PubMed ID: 18089372
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer in cardiothoracic transplant recipients.
Pollard JD; Hanasono MM; Mikulec AA; Le QT; Terris DJ
Laryngoscope; 2000 Aug; 110(8):1257-61. PubMed ID: 10942122
[TBL] [Abstract][Full Text] [Related]
19. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states.
Saigal S; Norris S; Srinivasan P; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2001 Jan; 7(1):11-5. PubMed ID: 11150415
[TBL] [Abstract][Full Text] [Related]
20. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
